ロード中...
When to Initiate Weight Loss Medications in the NAFLD Population
Nonalcoholic fatty liver disease (NAFLD) is characterized by histological evidence of hepatic steatosis, lobular inflammation, ballooning degeneration and hepatic fibrosis in the absence of significant alcohol use and other known causes of chronic liver diseases. NAFLD is subdivided into nonalcoholi...
保存先:
| 出版年: | Diseases |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6313489/ https://ncbi.nlm.nih.gov/pubmed/30274326 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diseases6040091 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|